|
시장보고서
상품코드
1886399
말 수의 치료제 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 약제별, 투여 경로별, 유통경로별, 지역별, 경쟁별 세분화(2020-2030년)Equine Veterinary Therapeutics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F |
||||||
세계의 말 수의료 치료제 시장은 2024년에 18억 2,000만 달러로 평가되며, 2030년까지 CAGR 7.21%로 성장하며, 27억 6,000만 달러에 달할 것으로 예측됩니다. 세계 말용 수의 치료제 시장은 말의 건강 유지 및 회복을 목적으로 특별히 개발된 의약품, 백신, 진단 툴 등을 포함합니다. 이 시장의 성장은 주로 다양한 말의 질병 증가 추세, 말 소유자의 동물 복지 및 예방 의료에 대한 인식 증가, 그리고 세계 승마 스포츠의 지속적인 확장에 의해 주도되고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 18억 2,000만 달러 |
| 시장 규모 : 2030년 | 27억 6,000만 달러 |
| CAGR : 2025-2030년 | 7.21% |
| 가장 빠르게 성장하는 부문 | 항염증 |
| 최대 시장 | 북미 |
주요 시장 성장 촉진요인
말의 건강에 대한 인식 증가와 예방의료의 보급이 세계 말용 동물용 의약품 시장을 크게 견인하고 있습니다. 말 소유주들은 예방적 헬스케어의 장기적인 이점을 점점 더 많이 인식하고 있으며, 백신, 구충제, 영양 보충제에 대한 수요가 증가하고 있습니다.
주요 시장 과제
숙련된 말 수의사의 만성적인 부족은 세계 말 수의 치료제 시장 확대에 큰 걸림돌이 되고 있습니다. 수의사 수가 제한되어 있으며, 정기적인 건강검진, 질병 진단, 중요한 의약품 및 백신 투여와 같은 필수적인 수의 의료 서비스에 대한 접근이 직접적으로 제한되고 있습니다.
주요 시장 동향
개별화된 말 치료 계획으로의 전환은 표준화된 프로토콜을 넘어 개별 말의 생리적, 유전적 특성에 따른 대응을 실현하는 중요한 진화입니다. 이 접근법에서는 유전자 검사를 포함한 첨단 진단 기술을 활용하여 표적화된 치료적 개입을 위한 가이드라인을 제시합니다.
자주 묻는 질문
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 말 수의 치료제 시장 전망
- 시장 규모·예측
- 금액별
- 시장 점유율·예측
- 약제별(항염증약, 항감염약, 구충제, 기타)
- 투여 경로별(경구, 친화성, 국소)
- 유통 채널별(동물병원, 동물 진료소, 약국·드러그스토어, E-Commerce, 기타)
- 지역별
- 기업별(2024)
- 시장 맵
제6장 북미의 말 수의 치료제 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코
제7장 유럽의 말 수의 치료제 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
제8장 아시아태평양의 말 수의 치료제 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주
제9장 중동 및 아프리카의 말 수의 치료제 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국
제10장 남미의 말 수의 치료제 시장 전망
- 시장 규모·예측
- 시장 점유율·예측
- 남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나
제11장 시장 역학
- 촉진요인
- 과제
제12장 시장 동향과 발전
- 합병·인수
- 제품 출시
- 최근 동향
제13장 세계의 말 수의 치료제 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
- 업계내 경쟁
- 신규 참여의 가능성
- 공급업체의 힘
- 고객의 힘
- 대체품의 위협
제15장 경쟁 구도
- Merck & Co., Inc.
- Thermo Fisher Scientific Inc(Affymetrix)
- Elanco Animal Health Inc.
- Zoetis Services LLC
- Farnam Companies, Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSAThe Global Equine Veterinary Therapeutics Market, valued at USD 1.82 Billion in 2024, is projected to experience a CAGR of 7.21% to reach USD 2.76 Billion by 2030. The Global Equine Veterinary Therapeutics Market encompasses pharmaceuticals, vaccines, and diagnostic tools specifically developed to maintain and restore the health of horses. This market's growth is primarily driven by the increasing prevalence of various equine diseases, a heightened awareness among horse owners regarding animal welfare and preventive care, and the sustained expansion of equestrian sports globally.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.82 Billion |
| Market Size 2030 | USD 2.76 Billion |
| CAGR 2025-2030 | 7.21% |
| Fastest Growing Segment | Anti-Inflammatory |
| Largest Market | North America |
Key Market Drivers
Increased equine health awareness and the rising adoption of preventative care significantly drive the global equine veterinary therapeutics market. Horse owners are increasingly recognizing the long-term benefits of proactive health management, leading to greater demand for vaccines, parasiticides, and nutritional supplements. This shift towards preventative strategies minimizes the incidence and severity of diseases, thereby necessitating a steady supply of efficacious therapeutics for routine immunization and health maintenance.
Key Market Challenges
The persistent shortage of skilled equine veterinarians represents a significant impediment to the expansion of the Global Equine Veterinary Therapeutics Market. A limited number of practitioners directly restricts the accessibility of essential veterinary services, including routine health examinations, disease diagnosis, and the administration of critical pharmaceuticals and vaccines. This constraint means that even with advanced therapeutics available, their deployment to the substantial equine population is bottlenecked by the human resources required for delivery and oversight.
Key Market Trends
The shift towards personalized equine treatment plans represents a critical evolution, moving beyond standardized protocols to cater to the individual physiological and genetic makeup of each horse. This approach leverages advanced diagnostics, including genetic testing, to inform targeted therapeutic interventions.
Key Market Players
- Merck & Co., Inc.
- Thermo Fisher Scientific Inc (Affymetrix)
- Elanco Animal Health Inc.
- Zoetis Services LLC
- Farnam Companies, Inc.
Report Scope:
In this report, the Global Equine Veterinary Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Equine Veterinary Therapeutics Market, By Drugs:
- Anti-Inflammatory
- Anti-Infective
- Parasiticides
- Others
Equine Veterinary Therapeutics Market, By Route of Administration:
- Oral
- Parental
- Topical
Equine Veterinary Therapeutics Market, By Distribution Channel:
- Veterinary Hospital
- Veterinary Clinics
- Pharmacies and drugstores
- E-commerce
- Other
Equine Veterinary Therapeutics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Equine Veterinary Therapeutics Market.
Available Customizations:
Global Equine Veterinary Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Equine Veterinary Therapeutics Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Drugs (Anti-Inflammatory, Anti-Infective, Parasiticides, Others)
- 5.2.2. By Route of Administration (Oral, Parental, Topical)
- 5.2.3. By Distribution Channel (Veterinary Hospital, Veterinary Clinics, Pharmacies and drugstores, E-commerce, Other)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
- 5.3. Market Map
6. North America Equine Veterinary Therapeutics Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Drugs
- 6.2.2. By Route of Administration
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Equine Veterinary Therapeutics Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Drugs
- 6.3.1.2.2. By Route of Administration
- 6.3.1.2.3. By Distribution Channel
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Equine Veterinary Therapeutics Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Drugs
- 6.3.2.2.2. By Route of Administration
- 6.3.2.2.3. By Distribution Channel
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Equine Veterinary Therapeutics Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Drugs
- 6.3.3.2.2. By Route of Administration
- 6.3.3.2.3. By Distribution Channel
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Equine Veterinary Therapeutics Market Outlook
7. Europe Equine Veterinary Therapeutics Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Drugs
- 7.2.2. By Route of Administration
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Equine Veterinary Therapeutics Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Drugs
- 7.3.1.2.2. By Route of Administration
- 7.3.1.2.3. By Distribution Channel
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Equine Veterinary Therapeutics Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Drugs
- 7.3.2.2.2. By Route of Administration
- 7.3.2.2.3. By Distribution Channel
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Equine Veterinary Therapeutics Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Drugs
- 7.3.3.2.2. By Route of Administration
- 7.3.3.2.3. By Distribution Channel
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Equine Veterinary Therapeutics Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Drugs
- 7.3.4.2.2. By Route of Administration
- 7.3.4.2.3. By Distribution Channel
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Equine Veterinary Therapeutics Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Drugs
- 7.3.5.2.2. By Route of Administration
- 7.3.5.2.3. By Distribution Channel
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Equine Veterinary Therapeutics Market Outlook
8. Asia Pacific Equine Veterinary Therapeutics Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Drugs
- 8.2.2. By Route of Administration
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Equine Veterinary Therapeutics Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Drugs
- 8.3.1.2.2. By Route of Administration
- 8.3.1.2.3. By Distribution Channel
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Equine Veterinary Therapeutics Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Drugs
- 8.3.2.2.2. By Route of Administration
- 8.3.2.2.3. By Distribution Channel
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Equine Veterinary Therapeutics Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Drugs
- 8.3.3.2.2. By Route of Administration
- 8.3.3.2.3. By Distribution Channel
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Equine Veterinary Therapeutics Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Drugs
- 8.3.4.2.2. By Route of Administration
- 8.3.4.2.3. By Distribution Channel
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Equine Veterinary Therapeutics Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Drugs
- 8.3.5.2.2. By Route of Administration
- 8.3.5.2.3. By Distribution Channel
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Equine Veterinary Therapeutics Market Outlook
9. Middle East & Africa Equine Veterinary Therapeutics Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Drugs
- 9.2.2. By Route of Administration
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Equine Veterinary Therapeutics Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Drugs
- 9.3.1.2.2. By Route of Administration
- 9.3.1.2.3. By Distribution Channel
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Equine Veterinary Therapeutics Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Drugs
- 9.3.2.2.2. By Route of Administration
- 9.3.2.2.3. By Distribution Channel
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Equine Veterinary Therapeutics Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Drugs
- 9.3.3.2.2. By Route of Administration
- 9.3.3.2.3. By Distribution Channel
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Equine Veterinary Therapeutics Market Outlook
10. South America Equine Veterinary Therapeutics Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Drugs
- 10.2.2. By Route of Administration
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Equine Veterinary Therapeutics Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Drugs
- 10.3.1.2.2. By Route of Administration
- 10.3.1.2.3. By Distribution Channel
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Equine Veterinary Therapeutics Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Drugs
- 10.3.2.2.2. By Route of Administration
- 10.3.2.2.3. By Distribution Channel
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Equine Veterinary Therapeutics Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Drugs
- 10.3.3.2.2. By Route of Administration
- 10.3.3.2.3. By Distribution Channel
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Equine Veterinary Therapeutics Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Equine Veterinary Therapeutics Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Merck & Co., Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. Thermo Fisher Scientific Inc (Affymetrix)
- 15.3. Elanco Animal Health Inc.
- 15.4. Zoetis Services LLC
- 15.5. Farnam Companies, Inc.
